Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ce/21/d9/ce21d9ef-3dd1-87db-a52f-8531dc0a98b9/mza_989454734674919629.jpg/600x600bb.jpg
Race and Regulation
Penn Program on Regulation
12 episodes
2 weeks ago
Administrative law has a racial blind spot, argues Daniel E. Ho of Stanford Law School. Judges have long set aside agency actions when government officials have failed to consider the differential impacts of their policy decisions on subgroups of business owners, park visitors, and even animals — but not when they have failed to consider differential impacts based on race or ethnicity. In this episode, Professor Ho traces how civil rights and administrative law have diverged over the past fif...
Show more...
Government
RSS
All content for Race and Regulation is the property of Penn Program on Regulation and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Administrative law has a racial blind spot, argues Daniel E. Ho of Stanford Law School. Judges have long set aside agency actions when government officials have failed to consider the differential impacts of their policy decisions on subgroups of business owners, park visitors, and even animals — but not when they have failed to consider differential impacts based on race or ethnicity. In this episode, Professor Ho traces how civil rights and administrative law have diverged over the past fif...
Show more...
Government
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ce/21/d9/ce21d9ef-3dd1-87db-a52f-8531dc0a98b9/mza_989454734674919629.jpg/600x600bb.jpg
Race, Social Inequalities, and Clinical Drug Trials: Jill Fisher
Race and Regulation
30 minutes
3 years ago
Race, Social Inequalities, and Clinical Drug Trials: Jill Fisher
As mandated by the U.S. Food and Drug Administration, clinical trials for new pharmaceuticals enroll healthy people as paid research participants to test for drug safety and tolerability. But the social injustices from these trials are too often overlooked. Drawing on her award-winning book, Adverse Events, Jill Fisher of UNC-Chapel Hill’s Center for Bioethics explains how clinical drug trials attract disproportionate participation by racial and ethnic minorities who then disproportionately a...
Race and Regulation
Administrative law has a racial blind spot, argues Daniel E. Ho of Stanford Law School. Judges have long set aside agency actions when government officials have failed to consider the differential impacts of their policy decisions on subgroups of business owners, park visitors, and even animals — but not when they have failed to consider differential impacts based on race or ethnicity. In this episode, Professor Ho traces how civil rights and administrative law have diverged over the past fif...